Projected Income Statement: Damartex

Forecast Balance Sheet: Damartex

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -25.9 48 81.9 105 120 115 111 113
Change - 285.33% 70.63% 28.21% 14.29% -3.85% -3.48% 1.8%
Announcement Date 9/8/21 9/7/22 9/5/23 11/8/24 11/1/25 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Damartex

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 9.2 16.5 14.8 9.228 10.79 30.2 30.2 30.2
Change - 79.35% -10.3% -37.65% 16.92% 179.91% 0% 0%
Free Cash Flow (FCF) 1 52.72 -23.8 -0.96 20.98 19.85 -11.9 -4.2 -1.7
Change - -145.15% 95.97% 2,285.42% -5.38% -159.95% 64.71% 59.52%
Announcement Date 9/8/21 9/7/22 9/5/23 11/8/24 11/1/25 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Damartex

Fiscal Period: June 2020 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

         
EBITDA Margin (%) - 6.91% 3.64% 2.68% 1.82% 6.75% 6.93% 7.03% 8.33%
EBIT Margin (%) - 2.88% -0.38% -2.66% -0.28% 0.41% 0.28% 0.78% 2.54%
EBT Margin (%) - 2.77% -0.29% -5.06% -7.33% -2.46% -2.5% -1.9% -0.12%
Net margin (%) - 2.13% -0.81% -5.01% -6.62% -3.38% -2.5% -1.9% -0.12%
FCF margin (%) - 6.9% -3.31% -0.15% 3.96% 3.81% -2.36% -0.84% -0.33%
FCF / Net Income (%) - 323.42% 410.34% 2.94% -59.88% -112.77% 94.44% 44.21% 283.33%

Profitability

         
ROA -4.3% 2.45% -0.33% -2.12% -0.19% 0.3% - - -
ROE -45.09% 12.52% -3.7% -23.88% -33.24% -19.02% - - -

Financial Health

         
Leverage (Debt/EBITDA) - - 1.83x 4.71x 10.9x 3.4x 3.29x 3.17x 2.67x
Debt / Free cash flow - - -2.02x -85.31x 4.99x 6.02x -9.66x -26.48x -66.41x

Capital Intensity

         
CAPEX / Current Assets (%) - 1.2% 2.29% 2.28% 1.74% 2.07% 6% 6.05% 5.95%
CAPEX / EBITDA (%) - 17.42% 62.98% 85.06% 96.03% 30.65% 86.53% 86.04% 71.39%
CAPEX / FCF (%) - 17.45% -69.33% -1,541.67% 43.98% 54.35% -253.78% -719.05% -1,776.47%

Items per share

         
Cash flow per share 1 - 6.617 -2.92 1.233 2.687 2.668 1.9 1.9 2.6
Change - - -144.13% 142.23% 117.93% -0.7% -28.79% 0% 36.84%
Dividend per Share 1 - 0.4 0.1 - - - - - -
Change - - -75% - - - - - -
Book Value Per Share 1 - 14.11 14.05 10.3 8.065 6.264 5.1 4.3 4.2
Change - - -0.43% -26.69% -21.7% -22.33% -18.58% -15.69% -2.33%
EPS 1 - 1.74 -0.52 -2.92 -3.12 -1.57 -1.12 -0.85 -0.05
Change - - -129.89% -461.54% -6.85% 49.68% 28.66% 24.11% 94.12%
Nbr of stocks (in thousands) - 11,116 11,164 11,182 11,243 11,242 11,255 11,255 11,255
Announcement Date - 9/8/21 9/7/22 9/5/23 11/8/24 11/1/25 - - -
1EUR
Estimates
2026 *2027 *
P/E -2.28x -3x
PBR 0.5x 0.59x
EV / Sales 0.29x 0.28x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
2.550EUR
Average target price
2.600EUR
Spread / Average Target
+1.96%

Annual profits - Rate of surprise